Joinstar Biomedical Technology Co., Ltd.
JOINSTAR is the first company in the world to provide the innovative diagnostic tests in early diagnosis, prediction, monitoring and prognosis management of sepsis. Our tests enable hospitals and labs to deliver that information quickly and reliably. HBP(Heparin Binding Protein),a new biomarker, the study results that HBP is an early diagnostic marker of infection-related organ dysfunction and can reliably predict whether infected patients will progress to severe sepsis within 72 hours.